Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00690534 · ClinicalTrials.gov registry record · Phase 1
Insulin and Sarcopenia in the Elderly
A Phase 1 study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- Phase 1
- Development phase
- 88
- Enrollment target
NCT00690534 is a Phase 1 study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 88 participants.
The verdict
NCT00690534, a Phase 1 study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 88 participants
- Enrollment target
Study Summary
Muscle loss with aging is a significant contributor to disability in older people. Our general hypothesis is that loss of muscle with aging, known as sarcopenia, may be due to inability of muscle to grow in response to insulin. Our goal is to determine the mechanisms underlying this age-related insulin resistance of muscle proteins, which will allow us to define in the future specific interventions to target this defect and provide the scientific basis for the prevention and treatment of sarcopenia.
Interventions
- DRUG Sodium Nitroprusside
- DRUG L-NMMA
- DRUG Insulin Regular
- OTHER mixed meal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2005-09 |
| Est. Completion | 2012-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00690534
The ClinicalTrials.gov registry entry for NCT00690534 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Sodium Nitroprusside is the first listed.
NCT00690534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00690534 about?
NCT00690534 is a clinical study titled "Insulin and Sarcopenia in the Elderly". Muscle loss with aging is a significant contributor to disability in older people. Our general hypothesis is that loss of muscle with aging, known as sarcopenia, may be due to inability of muscle to grow in response to insulin. Our goal is to determine the mechanisms underlying this age-related insu...
What is the current status of trial NCT00690534?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 88 participants. The study started on 2005-09. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00690534?
The interventions under investigation include: Sodium Nitroprusside (DRUG), L-NMMA (DRUG), Insulin Regular (DRUG), mixed meal (OTHER).
Who is sponsoring clinical trial NCT00690534?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.